
    
      Study D9180C00002 is a Phase II, randomised, double-blind, placebo-controlled, parallel
      group, proof of concept study to evaluate the efficacy and safety of MEDI3506 in adult
      participants with moderate to severe Chronic Obstructive Pulmonary Disease and Chronic
      Bonchitis.

      Approximately 112 sites globally will participate in this study. Approximately 322
      participants will be randomized to 2 treatment groups in a 1:1 ratio to receive MEDI3506 or
      placebo.
    
  